Sustainable Ag 1 | MBIDAVIS, Calif., Oct 22, 2018 – Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, today announced that the International Biocontrol Manufacturers Association (IBMA) awarded MBI the 2018 Bernard Blum Award for a Novel Biocontrol Solution at its annual general assembly in Basel, Switzerland.

The award was given for three products, Venerate® insecticide, Majestene® nematicide and MBI-014 herbicide, which are all based on a new species of non-living bacteria, Burkholderia rinojensis. This species, which was discovered by MBI, produces several natural compounds with notable pesticidal activity, which work together to control a broad range of pests and weeds, while remaining non-toxic and low risk to non-target organisms, such as honeybees.

The three distinct products, derived from a single microbe, meet important grower needs in today’s changing environment of pest control options and increasing channel demands. Venerate controls many chewing and sucking insects and mites, as well as flies on crops such as almonds, leafy greens, grapes, citrus, apples, berries and coffee. Majestene controls root knot, dagger, burrowing, sting, cyst and other plant parasitic nematodes on crops such as potatoes, cucurbits, bananas, berries, and turf. MBI-014, recently submitted to the EPA, is particularly strong on glyphosate-resistant weeds in the pigweed family. Its novel mode of action is one of the few, if any, new herbicidal modes of action since the 1980s.

“We are proud to have won such a prestigious award within the biological pest management industry,” said Pam Marrone, CEO and Founder of Marrone Bio Innovations. “We thank the IBMA for recognizing the innovative work our scientists perform every day. The unique microbe we discovered, Burkholderia rinojensis, is effective across an unmatched spectrum of target pests, including weeds, insects, mites and nematodes, while remaining low risk to non-target organisms. We look forward to continuing to bring innovative new biological pest control solutions to market in order to help farmers solve some of their toughest problems,” concluded Marrone.

The Bernard Blum award and trophy are dedicated to IBMA’s founding father, who laid the foundation for the IBMA in 1995 after observing an important and growing industry in the field of plant protection. Every year since 2015, an independent jury selects a winning biocontrol product, among a number of entries, which provides an effective solution in the management of pests or diseases while having a low impact on human health and the environment.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) strives to lead the movement to more sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment. MBI has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies to rapidly develop seven effective and environmentally responsible pest management products to help customers operate more sustainably while uniquely improving plant health and increasing crop yields. Supported by a robust portfolio of over 400 issued and pending patents around its superior natural product chemistry, MBI’s currently available commercial products are Regalia®, Grandevo®, Venerate®, Majestene®, Haven® Stargus® and Amplitude™, Zelto® and Zequanox®.

Marrone Bio Innovations is dedicated to pioneering smart biopesticide solutions that support a better tomorrow for both farmers, turf managers and consumers around the globe. For more information, please visit

Marrone Bio Innovations Forward Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing MBI’s views as of any subsequent date. Examples of such statements include the potential of the Bernard Blum award to drive sales, provide market projections, and realize the potential benefits of our products. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company’s control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including weather, regulatory and other factors affecting demand for the MBI’s products, any difficulty in marketing MBI’s products in its target markets, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers. Additional information that could lead to material changes in MBI’s performance is contained in its filings with the SEC. MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of current information, future events or otherwise.

Marrone Bio Innovations Contacts:
Pam Marrone, CEO and Founder
Telephone: +1 (530) 750-2800

MBI Investor Relations:
Greg Falesnik
Managing Director
MZ Group – MZ North America
Main: 949-385-6449

MBI Trade Public Relations:
Alicia Gillman
Marketing Communications
Office: 480-889-4219